TP53 and neoplasm: It should also be mentioned here, that TP53 mutations are overrepresented among the baseline samples of the current study, because all cases with detectable TP53 mutations at diagnosis were included, but several initially TP53 wild-type tumours had to be excluded, because no TP53 reassessment was available.